Richard Lehrer, MD
Ophthalmology · Alliance, OHNPI 1477520393
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2019 at $3,752 and has fallen 98.3% since, to $62 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $58.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$3K
- Bausch & Lomb Americas Inc.$2K
- Ivantis, Inc$1K
- AbbVie$1K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$670
- plus $3K from 18 others
Across 65 payments — averaging $1458.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$95K
What the payments were for
- Consulting fees$2,01617%
- Speaking & faculty fees$2,00017%
- Travel & lodging$5995%
- Food & beverage$6,70158%
- Education$2752%
- Gifts$450%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 16 | $2,726 |
| Bausch & Lomb Americas Inc. | 12 | $2,270 |
| Ivantis, Inc | 9 | $1,181 |
| AbbVie(2 entities) | 48 | $1,151 |
| Johnson & Johnson Surgical Vision, Inc. | 15 | $1,027 |
| Alcon | 19 | $670 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $570 |
| NEW World Medical,inc. | 11 | $483 |
| Ocular Therapeutix, Inc. | 10 | $277 |
| Mallinckrodt Hospital Products Inc. | 4 | $242 |
| Aerie Pharmaceuticals, Inc. | 5 | $239 |
| Dompe US, Inc. | 4 | $193 |
| Novartis | 5 | $97 |
| Rayner Intraocular Lenses Limited | 6 | $93 |
| Kala Pharmaceuticals, Inc. | 6 | $88 |
| Amgen | 4 | $62 |
| Oyster Point Pharma, Inc. | 3 | $60 |
| Pulpdent Corporation | 1 | $47 |
| Omeros Corporation | 3 | $42 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| Sight Sciences, Inc. | 2 | $28 |
| Biotissue Holdings Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $22 |
| LKC Technologies, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent Trabecular Micro-Bypass Stent System$2,000
- VYZULTA$1,748
- Hydrus$725
- Hydrus Microstent$637
- Tecnis 1-piece IOL$570
- Tecnis Multifocal Family of 1-piece IOLS$570
- Tecnis Symfony IOL$570
- Ahmed Glaucoma Valve$300
- Kahook Dual Blade$300
- DEXTENZA$300
- iDose TR$160
- Streamline Surgical System$150
- MIEBO$149
- XIIDRA$149
- enVista MX60 IOL$149
- STELLARIS ELITE$149
- LOTEMAX SM$148
- Rocklatan$139
- Rhopressa$139
- Oxervate$138
How this compares
$11,636 in reported general payments places this provider in the 90th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 251 | $135,165 |
| VyzultaLatanoprostene Bunod | 151 | $79,408 |
| CombiganBrimonidine Tartrate/Timolol | 74 | $31,597 |
| RhopressaNetarsudil Mesylate | 71 | $28,705 |
| RestasisCyclosporine | 13 | $14,047 |
| Alphagan PBrimonidine Tartrate | 30 | $10,987 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 63 | $10,958 |
| RocklatanNetarsudil Mesylat/Latanoprost | 26 | $10,332 |
| Travoprost | 44 | $8,827 |
| Bimatoprost | 68 | $6,881 |
| Prednisolone Acetate | 143 | $6,878 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 22 | $5,855 |
| Brimonidine Tartrate | 266 | $5,789 |
| Latanoprost | 385 | $4,668 |
| Fluorometholone | 73 | $4,240 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Restasis, Alphagan P | $1,151 | $191,796368 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $2,270 | $79,408151 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $239 | $39,03897 claims |
| AlconSimbrinza | $670 | $5,85522 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $570 | $2,10516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 640 ophthalmology providers in Ohio.
Other ophthalmology in Alliance
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
- Robert OsherCincinnati$720K
- Justis EhlersCleveland$639K
- Lawrence SingermanBeachwood$599K
- Darrell WhiteWestlake$587K
- Alice EpitropoulosColumbus$531K
- Amy MillerDayton$526K
- Sunil SrivastavaCleveland$508K
- William WileyCleveland$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.